Dosage of adjuvant G-CSF (filgrastim)-supported FEC polychemotherapy based on equivalent haematological toxicity in high-risk breast cancer patients
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/9/4/403/19481784/9-4-403.pdf
Reference30 articles.
1. A formula to estimate the aproximate surface area if height and weight be known;Du Bois;Arch Intern Med,1916
2. Dose calculation of anticancer drugs: A review of the current practice and introduction of an alternative;Gurney;J Clin Oncol,1996
3. Is dose normalization to weight or body surface area useful in adults?;Grochow;J Natl Cancer Inst,1990
4. Lack of relationship between systemic exposure for the component drugs of the fluorouracil, epirubicin, and 4-hydroxycyclophosphamide regimen in breast cancer patients;Sandström;J Clin Oncol,1996
5. Clinical pharmacokinetics-pharmacodynamics of anticancer drugs;Evans;Clin Pharmacokinet,1989
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review;Journal of Global Oncology;2018-12
2. Impact of chemotherapy-induced neutropenia (CIN) and febrile neutropenia (FN) on cancer treatment outcomes: An overview about well-established and recently emerging clinical data;Critical Reviews in Oncology/Hematology;2017-12
3. Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies;Expert Review of Anticancer Therapy;2017-09-25
4. A nested cohort study of 6,248 early breast cancer patients treated in neoadjuvant and adjuvant chemotherapy trials investigating the prognostic value of chemotherapy-related toxicities;BMC Medicine;2015-12
5. Individually tailored toxicity-based 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy of metastatic breast cancer;Acta Oncologica;2007-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3